Stay-at-home trial for people with Parkinson’s disease
New Trial of a Breakthrough Device*
Aims to Improve Quality of Life
A promising, convenient device is being developed for non-motor symptoms in PD.
Will you help us determine its effectiveness? Anyone with Parkinson’s from across the United States can apply – even those in remote locations as long as
they have an internet connection.
Treatment
and doctor visits
from home
The trial features a
specialized light therapy device
that can be used while participants
enjoy normal daily activities.
The trial is free to participants and participants will be compensated for their time.
The device is safe and convenient, and participation will not increase their risk for COVID-19 infection.
Focused
on non-motor symptoms
Common non-motor issues include sleep, depression, anxiety, and apathy. No current PD therapy addresses general non-motor issues, which can be more debilitating than motor issues and can lead
to reduced quality of life.
Works with
your existing medications
Participants will not need to alter
their existing medical regime and will need to keep the same medicines
for six months.
Participants must be on stable dopaminergic therapy.
The Celeste device can be
used in conjunction with
current medical care.
The Celeste Light for PD Trial consists of
four video conferences visits during six months with only 300 participants.
Most people with Parkinson’s are eligible. Act now to see if you qualify.
The Celeste Light was granted Breakthrough Device* designation by the FDA in 2020.
If successful, the Celeste light device will be
the first therapy to improve general non-motor symptoms and improve overall function.